parecoxib (Dynastat)
Jump to navigation
Jump to search
Introduction
In pipeline. Mid 2002. 1st injectable COX-2 inhibitor. FDA approval rejected in 2005.[3]
Prodrug of valdecoxib (Bextra).
Manufacturer: Pharmacia.
More general terms
References
- ↑ Prescriber's Letter 8(11):61 2001
- ↑ Journal Watch 25(6):52, 2005
- ↑ 3.0 3.1 FDA rejects parecoxib, only injectable COX-2 inhibitor http://www.medscape.com/viewarticle/538344